Annual Accounts Payable
$750.00 K
+$653.00 K+673.20%
December 31, 2023
Summary
- As of February 26, 2025, AMPE annual accounts payable is $750.00 thousand, with the most recent change of +$653.00 thousand (+673.20%) on December 31, 2023.
- During the last 3 years, AMPE annual accounts payable has risen by +$564.00 thousand (+303.23%).
- AMPE annual accounts payable is now -77.27% below its all-time high of $3.30 million, reached on December 31, 2014.
Performance
AMPE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$750.00 K
+$291.00 K+63.40%
December 31, 2023
Summary
- As of February 26, 2025, AMPE quarterly accounts payable is $750.00 thousand, with the most recent change of +$291.00 thousand (+63.40%) on December 31, 2023.
- Over the past year, AMPE quarterly accounts payable has increased by +$653.00 thousand (+673.20%).
- AMPE quarterly accounts payable is now -83.04% below its all-time high of $4.42 million, reached on March 31, 2014.
Performance
AMPE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMPE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +673.2% | +673.2% |
| 3 y3 years | +303.2% | +303.2% |
| 5 y5 years | +6.2% | +6.2% |
AMPE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +673.2% | -52.6% | +673.2% |
| 5 y | 5-year | at high | +673.2% | -52.6% | +673.2% |
| alltime | all time | -77.3% | -100.0% | -83.0% | -100.0% |
Ampio Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $750.00 K(+673.2%) | $750.00 K(+63.4%) |
| Sep 2023 | - | $459.00 K(-26.8%) |
| Jun 2023 | - | $627.00 K(+9.0%) |
| Mar 2023 | - | $575.00 K(+492.8%) |
| Dec 2022 | $97.00 K(-77.3%) | $97.00 K(-55.5%) |
| Sep 2022 | - | $218.00 K(-69.6%) |
| Jun 2022 | - | $718.00 K(-54.6%) |
| Mar 2022 | - | $1.58 M(+270.5%) |
| Dec 2021 | $427.00 K(+129.6%) | $427.00 K(+39.1%) |
| Sep 2021 | - | $307.00 K(+80.6%) |
| Jun 2021 | - | $170.00 K(+34.9%) |
| Mar 2021 | - | $126.00 K(-32.3%) |
| Dec 2020 | $186.00 K(+23.2%) | $186.00 K(-53.3%) |
| Sep 2020 | - | $398.00 K(-7.9%) |
| Jun 2020 | - | $432.00 K(-64.8%) |
| Mar 2020 | - | $1.23 M(+711.9%) |
| Dec 2019 | $151.00 K(-78.6%) | $151.00 K(-72.1%) |
| Sep 2019 | - | $542.00 K(-23.2%) |
| Dec 2018 | $706.00 K(-78.6%) | $706.00 K(-38.4%) |
| Sep 2016 | - | $1.15 M(-16.2%) |
| Jun 2016 | - | $1.37 M(-38.1%) |
| Mar 2016 | - | $2.21 M(-4.3%) |
| Sep 2015 | - | $2.31 M(-6.3%) |
| Jun 2015 | - | $2.47 M(+62.2%) |
| Mar 2015 | - | $1.52 M(-53.9%) |
| Dec 2014 | $3.30 M | $3.30 M(+16.0%) |
| Sep 2014 | - | $2.84 M(-21.8%) |
| Jun 2014 | - | $3.64 M(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $4.42 M(+132.7%) |
| Dec 2013 | $1.90 M(+58.2%) | $1.90 M(+62.9%) |
| Sep 2013 | - | $1.17 M(-33.7%) |
| Jun 2013 | - | $1.76 M(+50.4%) |
| Mar 2013 | - | $1.17 M(-2.6%) |
| Dec 2012 | $1.20 M(+90.5%) | $1.20 M(+52.2%) |
| Sep 2012 | - | $789.40 K(+120.4%) |
| Jun 2012 | - | $358.10 K(-11.9%) |
| Mar 2012 | - | $406.40 K(-35.6%) |
| Dec 2011 | $630.60 K(+35.8%) | $630.60 K(+33.9%) |
| Sep 2011 | - | $471.00 K(-17.2%) |
| Jun 2011 | - | $568.90 K(+94.6%) |
| Mar 2011 | - | $292.30 K(-37.1%) |
| Dec 2010 | $464.50 K(+485.0%) | $464.50 K(-9.1%) |
| Sep 2010 | - | $510.80 K(+43.0%) |
| Jun 2010 | - | $357.20 K(+67.7%) |
| Mar 2010 | - | $213.00 K(+168.3%) |
| Dec 2009 | $79.40 K(+1790.5%) | $79.40 K(+1746.5%) |
| Sep 2009 | - | $4300.00(+87.0%) |
| Jun 2009 | - | $2300.00(-62.9%) |
| Mar 2009 | - | $6200.00(+47.6%) |
| Dec 2008 | $4200.00(-66.9%) | $4200.00(-35.4%) |
| Sep 2008 | - | $6500.00(+47.7%) |
| Jun 2008 | - | $4400.00(-65.9%) |
| Mar 2008 | - | $12.90 K(+1.6%) |
| Dec 2007 | $12.70 K(>+9900.0%) | $12.70 K(+8.5%) |
| Sep 2007 | - | $11.70 K(>+9900.0%) |
| Dec 2006 | $0.00 | $0.00 |
FAQ
- What is Ampio Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual accounts payable year-on-year change?
- What is Ampio Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly accounts payable year-on-year change?
What is Ampio Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMPE is $750.00 K
What is the all time high annual accounts payable for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual accounts payable is $3.30 M
What is Ampio Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMPE annual accounts payable has changed by +$653.00 K (+673.20%)
What is Ampio Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMPE is $750.00 K
What is the all time high quarterly accounts payable for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly accounts payable is $4.42 M
What is Ampio Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMPE quarterly accounts payable has changed by +$653.00 K (+673.20%)